RETRACTED ARTICLE: Ibrutinib facilitates the sensitivity of colorectal cancer cells to ferroptosis through BTK/NRF2 pathway
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
RETRACTED ARTICLE: Ibrutinib facilitates the sensitivity of colorectal cancer cells to ferroptosis through BTK/NRF2 pathway ; volume:14 ; number:2 ; day:23 ; month:2 ; year:2023 ; pages:1-11 ; date:2.2023
Cell death & disease ; 14, Heft 2 (23.2.2023), 1-11, 2.2023
- Creator
-
Zhu, Jin-Feng
Liu, Yi
Li, Wen-Ting
Li, Ming-Hui
Zhen, Chao-Hui
Sun, Pei-Wei
Chen, Ji-Xin
Wu, Wen-Hao
Zeng, Wei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41419-023-05664-9
- URN
-
urn:nbn:de:101:1-2404220819387.038376391282
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhu, Jin-Feng
- Liu, Yi
- Li, Wen-Ting
- Li, Ming-Hui
- Zhen, Chao-Hui
- Sun, Pei-Wei
- Chen, Ji-Xin
- Wu, Wen-Hao
- Zeng, Wei
- SpringerLink (Online service)
Other Objects (12)
Retraction Note: Ibrutinib facilitates the sensitivity of colorectal cancer cells to ferroptosis through BTK/NRF2 pathway
Ibrutinib and novel BTK inhibitors in clinical development
Zielgerichtete Therapie mit Ibrutinib bei B-Zell-Lymphomen : BTK-Hemmung: Schlüssel zur CLL-Primärtherapie?
Etablierung einer Liquid Biopsy zur Detektion einer BTK Resistenzmutation bei Patienten unter Ibrutinib-Therapie
Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia
BTK
BTK
BTK
BTK
BTK
BTK
BTK
Retraction Note: Ibrutinib facilitates the sensitivity of colorectal cancer cells to ferroptosis through BTK/NRF2 pathway
Ibrutinib and novel BTK inhibitors in clinical development
Zielgerichtete Therapie mit Ibrutinib bei B-Zell-Lymphomen : BTK-Hemmung: Schlüssel zur CLL-Primärtherapie?
Etablierung einer Liquid Biopsy zur Detektion einer BTK Resistenzmutation bei Patienten unter Ibrutinib-Therapie
Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia
BTK
BTK
BTK
BTK
BTK
BTK
BTK
Retraction Note: Ibrutinib facilitates the sensitivity of colorectal cancer cells to ferroptosis through BTK/NRF2 pathway
Ibrutinib and novel BTK inhibitors in clinical development
Zielgerichtete Therapie mit Ibrutinib bei B-Zell-Lymphomen : BTK-Hemmung: Schlüssel zur CLL-Primärtherapie?
Etablierung einer Liquid Biopsy zur Detektion einer BTK Resistenzmutation bei Patienten unter Ibrutinib-Therapie
Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia
BTK
BTK
BTK
BTK
BTK
BTK